Tag: Novartis
What’s New in ADCs: 10th Annual World ADC Wrap-up
Hello ADC World:
We have something a little different in store for today. Today is a feature on the 10th Annual World ADC, held October...
Lonza Expands Bioconjugation Facility for the Commercial Manufacture of Third Antibody-drug...
Lonza, the Swiss Contract Development and Manufacturing Organization (CDMO), has confirmed the start of expansion to its bioconjugation facility in Visp, Switzerland together with...
Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals
Novartis announced that it has entered into an agreement and plan of merger with Endocyte, a US-based biopharmaceutical company focused on developing targeted therapeutics...
Drugs and Drug Hunters
All products of the creative process are a reflection of the individual makeup of the inventors. A painting by Mark Rothko looks like a...
London Calling: The Cutting-edge of Novel ADC Technologies
Major players in the rapidly advancing field of antibody drug conjugates (ADCs) will meet in London, United Kingdom, on 23-24 May for the annual...
